Page last updated: 2024-11-10

nsc73306

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID3003794
SCHEMBL ID14075836
SCHEMBL ID469855
MeSH IDM0499348

Synonyms (20)

Synonym
NCI60_041604
NCIMECH_000014 ,
79560-74-0
nsc-73304
NSC73306 ,
nsc73304
1-[(z)-(5,7-dichloro-2-oxo-indolin-3-ylidene)amino]-3-(4-methoxyphenyl)thiourea
5,7-dichloro-1h-indole-2,3-dione 3-(n-(4-methoxyphenyl)thiosemicarbazone)
NCIOPEN2_008732
AKOS000963121
CCG-35327
SCHEMBL14075836
SCHEMBL469855
DTXSID70417681
G3GZ237PUT ,
2-(5,7-dichloro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)-n-(4-methoxyphenyl)hydrazinecarbothioamide
1043426-80-7
hydrazinecarbothioamide, 2-(5,7-dichloro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)-n-(4-methoxyphenyl)-
unii-g3gz237put
874650-89-2

Research Excerpts

Overview

NSC73306 is a thiosemicarbazone compound that displays greater toxicity against cells expressing functional P-gp than against other cells.

ExcerptReferenceRelevance
"NSC73306 is a thiosemicarbazone compound that displays greater toxicity against cells expressing functional P-gp than against other cells."( Uptake of compounds that selectively kill multidrug-resistant cells: the copper transporter SLC31A1 (CTR1) increases cellular accumulation of the thiosemicarbazone NSC73306.
Fung, KL; Gottesman, MM; Hall, MD; Pixley, JN; Pluchino, KM; Pouliot, LM; Tepede, AK, 2014
)
1.32

Dosage Studied

ExcerptRelevanceReference
" TSC-H, TSC-F, and TSC-Cl exhibited a bell-shaped dose-response curve for the induction of apoptosis in K562 cells due to the change from apoptosis to necrosis as the principal mechanism of cell death at the highest tested doses."( Thiosemicarbazone p-Substituted Acetophenone Derivatives Promote the Loss of Mitochondrial Δψ, GSH Depletion, and Death in K562 Cells.
Basso, EA; Fernandes, CS; Kaiser, CR; Nantes, IL; Pessoto, FS; Prieto, T; Silva, AP; Yokomizo, CH, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]